Yd bio limited ordinary sharesYDES.US Overview
US StockHealthcare
(No presentation for YDES)

Browsing restrictions can be lifted for a fee.
-3.46%
Yd bio limited ordinary shares
-1.64%
Avg of Sector
-0.21%
S&P500
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2025Q4 | |||||||
| 2025Q3 | |||||||
| 2025Q2 | |||||||
| 2025Q1 |
At the end of the period, Yd bio limited ordinary shares (YDES) held Total Cash and Cash Equivalents of 6.31K, accounting for 0 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.